Ország: Egyesült Királyság
Nyelv: angol
Forrás: MHRA (Medicines & Healthcare Products Regulatory Agency)
Sodium chloride; Glucose
Baxter Healthcare Ltd
B05BB01
Sodium chloride; Glucose
9mg/1ml ; 50mg/1ml
Infusion
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 09020201
OBJECT 1 SODIUM CHLORIDE 0.9 % W/V AND GLUCOSE 5% W/V SOLUTION FOR INFUSION BP Summary of Product Characteristics Updated 01-Jun-2016 | Baxter Healthcare Ltd 1. Name of the medicinal product Sodium Chloride 0.9 % w/v and Glucose 5% w/v Solution for Infusion BP 2. Qualitative and quantitative composition Sodium Chloride: Glucose (as monohydrate): 9.0 g/l (0.9% w/v) 50.0 g/l (5.0% w/v) Each ml contains 50 mg glucose (as monohydrate) and 9.0 mg sodium chloride. Mmol/l: Meq/l: Na + : 154 Na + : 154 Cl - :154 Cl - :154 Nutritional value: approximately 840 kJ/l (or 200 kcal/l) For the full list of excipients, see section 6.1. 3. Pharmaceutical form Solution for infusion. Clear solution, free from visible particles. Osmolarity: 585 mosm/l (approx) pH: 3.5 to 6.5 4. Clinical particulars 4.1 Therapeutic indications Sodium Chloride 0.9 % w/v and Glucose 5% w/v solution is indicated for: - Treatment of sodium depletion, extracellular dehydration or hypovolaemia in cases where supply of water and carbohydrates is required due to restriction of the intake of fluids and electrolytes by normal routes. 4.2 Posology and method of administration The choice of the specific sodium chloride and glucose concentration, dosage, volume, rate and duration of administration depends on the age, weight, clinical condition of the patient and concomitant therapy. It should be determined by a physician. For patients with electrolyte and glucose abnormalities and for paediatric patients, consult a physician experienced in intravenous fluid therapy. Rapid correction of hyponatraemia and hypernatraemia is potentially dangerous (risk of serious neurologic complications). _ADULTS, OLDER PATIENTS AND ADOLESCENTS (AGE 12 YEARS AND OVER):_ The recommended dosage is: 500 ml to 3 L/24h Administration rate: The infusion rate is usually 40 ml/kg/24h and should not exceed the patient's glucose oxidation capacities in order to avoid hyperglycaemia. Therefore the maximum acute administration rate is 5 mg/kg/min. _PAEDIATRIC POPULATION_ The dosage varies with Olvassa el a teljes dokumentumot